Abstract

BackgroundIgA nephropathy (IgAN) involves mesangial matrix expansion, but the proteomic composition of this matrix is unknown. The present study aimed to characterize changes in extracellular matrix in IgAN.MethodsIn the present study we used mass spectrometry-based proteomics in order to quantitatively compare protein abundance between glomeruli of patients with IgAN (n = 25) and controls with normal biopsy findings (n = 15).ResultsUsing a previously published paper by Lennon et al. and cross-referencing with the Matrisome database we identified 179 extracellular matrix proteins. In the comparison between IgAN and controls, IgAN glomeruli showed significantly higher abundance of extracellular matrix structural proteins (e.g periostin, vitronectin, and extracellular matrix protein 1) and extracellular matrix associated proteins (e.g. azurocidin, myeloperoxidase, neutrophil elastase, matrix metalloproteinase-9 and matrix metalloproteinase 2). Periostin (fold change 3.3) and azurocidin (3.0) had the strongest fold change between IgAN and controls; periostin was also higher in IgAN patients who progressed to ESRD as compared to patients who did not.ConclusionIgAN is associated with widespread changes of the glomerular extracellular matrix proteome. Proteins important in glomerular sclerosis or inflammation seem to be most strongly increased and periostin might be an important marker of glomerular damage in IgAN.

Highlights

  • IgA nephropathy (IgAN) involves mesangial matrix expansion, but the proteomic composition of this matrix is unknown

  • IgAN is a disease characterized by glomerular extracellular matrix (ECM) expansion, but the glomerular proteomic changes have not been investigated in detail

  • Our study suggests that glomerular ECM changes in IgAN have strong similarities to changes seen in fibrosis development in general

Read more

Summary

Introduction

IgA nephropathy (IgAN) involves mesangial matrix expansion, but the proteomic composition of this matrix is unknown. The present study aimed to characterize changes in extracellular matrix in IgAN. IgA nephropathy (IgAN) is the most prevalent primary chronic glomerular disease worldwide [1], and benign in many cases, it is reported that up to 30–50% will slowly progress to end stage renal failure [2, 3]. The pathogenesis of IgAN involves mesangial deposition of immune-complexes containing galactose deficient IgA1 that leads to mesangial cell activation and initiation of glomerular injury [4]. Lennon et al previously described the protein composition of the glomerular ECM, identifying 144 structural and regulatory ECM proteins [7]. IgAN is a disease characterized by glomerular ECM expansion, but the glomerular proteomic changes have not been investigated in detail

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call